Dostarlimab

ATC L01FF07 · 10 markets · 13 records

Dostarlimab 10 markets · 13 records Forms

AU 3 records · 3 strengths

500 mg/10 mLinjectionJemperli also in GB·SG
500 mg/mLinjectionJEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial unknown

Records without a stated strength · 1 Jemperli

ES 2 records · 1 strengths

500 mginjectionJemperli

US 1 records · 1 strengths

50 mginjectionJemperli also in TW

GB 1 records · 1 strengths

500 mg/10 mLinjectionJemperli 500mg/10ml concentrate for solution for infusion vials also in AU·SG

CA 1 records · 1 strengths

50 mgliquidJemperli

SG 1 records · 1 strengths

500 mg/10 mLinjectionJEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML also in AU·GB

MX 1 records · 1 strengths

Records without a stated strength · 1 Jemperli

TW 1 records · 1 strengths

50 mginjectionJEMPERLI Concentrate for Solution for Infusion 50 mg/mL+1健沛利濃縮輸注液50毫克/毫升 also in US

HK 1 records · 1 strengths

Records without a stated strength · 1 JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Jemperli

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU
500 mg/10 mL injection	not recorded	Jemperli 500mg/10ml concentrate for solution for infusion vials	not recorded	Jemperli	JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg injection	Jemperli	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	JEMPERLI Concentrate for Solution for Infusion 50 mg/mL 健沛利濃縮輸注液50毫克/毫升	not recorded	not recorded
50 mg liquid	not recorded	not recorded	Jemperli	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
500 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	Jemperli	not recorded	not recorded	not recorded	not recorded
500 mg/mL injection	not recorded	not recorded	not recorded	JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Jemperli	not recorded	not recorded	not recorded	not recorded	JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML	Jemperli
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Jemperli	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in CA · ES · MX and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · ES · MX que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · ES · MX 有记录（未在本表显示）。另有 3 個規格/劑型僅在 CA · ES · MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.